Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for Detection of Thyroid Cancer in Patients Undergoing Diagnostic Fine Needle Aspirations of the Thyroid

NCT02778412 is registered in ClinicalTrials.gov with Pathway Genomics as lead sponsor.

NCT NCT02778412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02778412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for Detection of Thyroid Cancer in Patients Undergoing Diagnostic Fine Needle Aspirations of the Thyroid
Lead sponsor
Pathway Genomics
Phase
Observational
Overall status
Terminated
Start date
May 31, 2016
Completion date
August 31, 2017
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid adenoma, thyroid cancer, thyroid nodules, thyroiditis